Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
Details for Australian Patent Application No. 2002352843 (hide)
International Classifications
Event Publications
20 March 2003 Complete Application Filed
Priority application(s): 09/995,010 27.11.01 US
21 August 2003 Application Open to Public Inspection
Published as AU-B-2002352843
19 April 2007 Application Accepted
Published as AU-B-2002352843
16 August 2007 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002352844-THERMAL STIR WELDING PROCESS AND APPARATUS
2002352842-METHOD FOR SEMI-AUTOMATIC GENERATION AND BEHAVIORAL COMPARISON OF MODELS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser